Skip to main content
TipRanks
Go Ultimate75% OFF

Nautilus Biotechnolgy (NAUT) Stock Forecast & Price Target

243 Followers
See the Price Targets and Ratings of:

NAUT Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Nautilus Biotechnolgy in the past 3 months

NAUT Stock 12 Month Forecast

$4.00▲(72.41% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Nautilus Biotechnolgy in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 72.41% change from the last price of $2.32.
Highest Price Target$4.00Average Price Target$4.00Lowest Price Target$4.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for NAUT
Price TargetArticle
Roth MKM$3.50→$4buy72.41%UpsideReiterated10/28/26
Guggenheim Analyst forecast on NAUTUnknown AnalystNot RankedGuggenheim$4buy72.41%UpsideReiterated10/27/26
Leerink Partners Analyst forecast on NAUTUnknown AnalystNot RankedLeerink Partners$4buy72.41%UpsideInitiated09/09/26
TD Cowen―buy―Reiterated04/28/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
QUITAchieve Life Sciences
PALIPalisade Bio
KRSAKorsana Biosciences
HELPHelus Pharma
IRLAIRulya Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Nautilus Biotechnolgy

3 Months
Subbu Nambi
Subbu NambiGuggenheim
Success Rate7/9 ratings generated profit
78%
Average Return
+26.78%

Copying Subbu Nambi's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +26.78% per trade.

1 Year
Subbu Nambi
Subbu NambiGuggenheim
Success Rate6/9 ratings generated profit
67%
Average Return
+57.30%

Copying Subbu Nambi's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +57.30% per trade.

2 Years
Subbu Nambi
Subbu NambiGuggenheim
Success Rate6/9 ratings generated profit
67%
Average Return
+75.59%

Copying Subbu Nambi's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +75.59% per trade.

NAUT Analyst Recommendation Trends

01234Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for NAUT
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy11322
Buy00022
Hold00000
Sell00000
Strong Sell00000
total11344

In the current month, NAUT has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NAUT average Analyst price target in the past 3 months is 4.00.

NAUT Financial Forecast

$-2$-1.5$-1$-0.5$0Q1 2026Q3 2026Q4 2026
High$-0.10
Consensus$-0.14
Low$-0.15

NAUT Earnings Forecast

Next quarter’s earnings estimate for NAUT is -$0.14 with a range of -$0.15 to -$0.10. The previous quarter’s EPS was -$0.12. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$74,999.5$150,000$225,000.5$300,001Q1 2026Q3 2026Q4 2026
High$300K
Consensus$262K
Low$200K

NAUT Sales Forecast

Next quarter’s sales forecast for NAUT is $262.00K with a range of $200.00K to $300.00K. The previous quarter’s sales results were $234.00K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NAUT Stock Forecast FAQ

What is NAUT’s average 12-month price target, according to analysts?
Based on analyst ratings, Nautilus Biotechnolgy’s 12-month average price target is $4.00.
What is NAUT’s upside potential, based on the analysts’ average price target?
Nautilus Biotechnolgy has 72.41% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NAUT a Buy, Sell or Hold?
Nautilus Biotechnolgy has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Nautilus Biotechnolgy’s price target?
The average price target for Nautilus Biotechnolgy is $4.00. This is based on 3 12-month price targets, issued in the past 3 months. The highest analyst price target is $4.00, the lowest forecast is $4.00. The average price target represents a 72.41% increase from the current price of $2.32.
What do analysts say about Nautilus Biotechnolgy?
Nautilus Biotechnolgy’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of NAUT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.